Search

everythinglearnresearchcommunity

for

Search:↓

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Using finasteride with TIP extends time off period for prostate cancer patients.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Cured meats in Nigeria have high cadmium levels, posing health risks.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Finasteride does not prevent bladder cancer.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

No link found between hair loss severity and PSA levels in men.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.